Eli Lilly said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect. Starting Dec. 1, cash-paying patients ...
Ro said it will offer a "complete end-to-end" experience on a single platform and app, allowing eligible patients to receive a diagnosis and a prescription for Zepbound and have vials of the drug ...
Discover how Eli Lilly is increasing medical weight loss access in Indiana through Zepbound vials. Learn how this Indy ...
About a month after securing a label expansion from the FDA for multidose pen versions of Zepbound, Eli Lilly is making the KwikPens available to self-paying users of its direct-to-consumer drug sales ...
On the heels of striking a deal with the Trump administration to reduce the prices of several of its most popular drugs for U.S. patients, Eli Lilly has unveiled additional savings for cash-paying ...
Eli Lilly and Co. on Monday announced price cuts for starting single-dose vials of its weight-loss medication Zepbound, the latest in a series of moves to make its GLP-1 blockbuster more widely ...
Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results